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Community-based interventions for the prevention
and control of helmintic neglected tropical
diseases
Rehana A Salam1, Hasina Maredia2, Jai K Das1, Zohra S Lassi1 and Zulfiqar A Bhutta3,4*

Abstract
In this paper, we aim to systematically analyze the effectiveness of community-based interventions (CBIs) for the
prevention and control of helminthiasis including soil-transmitted helminthiasis (STH) (ascariasis, hookworms, and
trichuriasis), lymphatic filariasis, onchocerciasis, dracunculiasis, and schistosomiasis. We systematically reviewed
literature published before May 2013 and included 32 studies in this review. Findings from the meta-analysis
suggest that CBIs are effective in reducing the prevalence of STH (RR: 0.45, 95% CI: 0.38, 0.54), schistosomiasis
(RR: 0.40, 95% CI: 0.33, 0.50), and STH intensity (SMD: −3.16, 95 CI: −4.28, −2.04). They are also effective in improving
mean hemoglobin (SMD: 0.34, 95% CI: 0.20, 0.47) and reducing anemia prevalence (RR: 0.90, 95% CI: 0.85, 0.96).
However, it did not have any impact on ferritin, height, weight, low birth weight (LBW), or stillbirths. School-based
delivery significantly reduced STH (RR: 0.49, 95% CI: 0.39, 0.63) and schistosomiasis prevalence (RR: 0.50, 95% CI: 0.33,
0.75), STH intensity (SMD: −0.22, 95% CI: −0.26, −0.17), and anemia prevalence (RR: 0.87, 95% CI: 0.81, 0.94). It also
improved mean hemoglobin (SMD: 0.24, 95% CI: 0.16, 0.32). We did not find any conclusive evidence from the
quantitative synthesis on the relative effectiveness of integrated and non-integrated delivery strategies due to the
limited data available for each subgroup. However, the qualitative synthesis from the included studies supports
community-based delivery strategies and suggests that integrated prevention and control measures are more
effective in achieving greater coverage compared to the routine vertical delivery, albeit it requires an existing strong
healthcare infrastructure. Current evidence suggests that effective community-based strategies exist and deliver a range
of preventive, promotive, and therapeutic interventions to combat helminthic neglected tropical diseases (NTDs).
However, there is a need to implement and evaluate efficient integrated programs with the existing disease control
programs on a larger scale throughout resource-limited regions especially to reach the unreachable.
Keyword: Neglected tropical diseases, Soil-transmitted helminthiasis, Community-based interventions

Multilingual abstracts
Please see Additional file 1 for translations of the abstract
into the six official working languages of the United
Nations.
Introduction
Helminths (Greek, meaning ‘worms’) are parasitic worms
that have been harboring in humans throughout the
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ages. These are classified as nematodes or roundworms and include soil-transmitted helminths (ascariasis,
hookworms, and trichuriasis) and filarial (causing
lymphatic filariasis [LF] and onchocerciasis), whereas the
platyhelminthes or flatworms include the flukes (schistosomes) and tapeworms. As discussed in Paper 1 [1],
helminthic infections are a prominent subgroup within
neglected tropical diseases (NTDs), primarily perpetuated
due to a lack of access to safe water and sanitation. The
most common helminths are the soil-transmitted helminthiasis (STH), followed by schistosomiasis and LF.
These are often co-infectious, although the biology of each
disease differs. These infections disproportionately affect
children, pregnant women, and young adults resulting in
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serious chronic health conditions including malnutrition,
physical and intellectual growth retardations in children,
and adverse maternal, perinatal and delivery outcomes
among pregnant women [2-4]. Onchocerciasis is a leading
cause of blindness and skin disease, while LF is a major
cause of limb and genital deformities. For a more thorough discussion on the epidemiology and burden of
each of these diseases, please refer to our previous
publication [1].
Mass drug administration (MDA) with anthelminthics
has been a major approach to combat human helminthiasis while parallel interventions such as micronutrient
supplementation, especially iron, to combat associated
anemia has also been widely evaluated for effectiveness
[5]. Sanitation and education are also recommended, however, these are not always feasible in resource-limited settings. All these strategies can be effectively administered
via community delivery platforms. Child health days,
micronutrient supplementation, vaccination programs,
and school-based programs provide a potential entry point
for periodic deworming and health education in a more
cost-effective manner [6]. In this paper, we aim to systematically analyze the effectiveness of community-based
interventions (CBIs) for the prevention and control of
helminthiasis including STH (ascariasis, hookworms,
and trichuriasis), LF, onchocerciasis, dracunculiasis, and
schistosomiasis.

Methods
We systematically reviewed literature published before
May 2013 to identify studies on the effectiveness of the
community-based delivery of interventions highlighted
in our conceptual framework [7] for the outlined helminthic diseases. Our priority was to select existing randomized, quasi-randomized, and before-and-after studies
in which the intervention was delivered within community settings and the reported outcomes were relevant to
the diseases under review. A separate search strategy was
developed for each disease using appropriate keywords,
medical subject headings (MeSH), and free text terms.
Searches were conducted in the PubMed, Cochrane Libraries, Embase, and the World Health Organization
(WHO) Regional Databases. Studies that met the inclusion criteria were selected and double data was abstracted
on a standardized abstraction sheet. Quality assessment of
the included randomized controlled trials (RCTs) was
done using the Cochrane risk of bias assessment tool [8].
The outcomes of interest assessed for each of the above
diseases are outlined in Table 1. We conducted a metaanalysis for individual studies using the software Review
Manager 5.1. Pooled statistics were reported as the relative risk (RR) for categorical variables and standard mean
difference (SMD) for continuous variables between the experimental and control groups with 95% confidence
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Table 1 Outcomes analyzed
Outcomes

Outcomes analyzed

Morbidity

• Hookworm prevalence and intensity
• Ascaris prevalence and intensity
• Trichuris prevalence and intensity
• Schistosoma haematobium prevalence
• Schistosoma mansoni prevalence
• Schistosoma japonicum prevalence

Anthropometry

• Weight
• Height

Hematologic

• Prevalence of anemia
• Mean hemoglobin
• Serum ferritin

Birth outcomes

• Birth weight
• Low birth weigh
• Very low birth weight
• Stillbirths

intervals (CIs). We also attempted to qualitatively
synthesize the findings reported in the included studies
for other pragmatic parameters identified in our conceptual framework including intervention coverage, challenges/barriers, enabling factors, aspects related to
integrated delivery, monitoring, and evaluations and
equity. The detailed methodology is described in Paper 2
of this series [7].

Review
We identified 2,556 titles from the searches conducted
in all databases. After screening titles and abstracts, 208
full texts were reviewed, of which 32 studies (17 RCTs,
two quasi, and 13 before-and-after studies) were included in the review (see Figure 1). The characteristics
of the included studies are summarized in Table 2. Of
these 32 studies, four could not be included in the metaanalysis; one study [9] did not report any outcome of
interest, poolable data was not available in two studies
[10,11], while one [12] did not have a suitable control
group for comparison. We did not find any quantifiable
data from the studies on dracunculiasis, LF, and onchocerciasis to be included in the pooled analysis. For the
17 RCTs included in this review, randomization was adequate in 15 studies, allocation was concealed in six, and
adequate sequence generation was also done in six. All
studies provided insufficient information on selective
reporting which limited us from making any judgment
(see Table 3).
Included studies mainly focused on community-based
MDA, which involved preventive chemotherapy in 19 of
the studies and treatment after confirmed diagnosis in
11 studies. A school-based delivery strategy was the

Salam et al. Infectious Diseases of Poverty 2014, 3:23
http://www.idpjournal.com/content/3/1/23

Page 3 of 17

2556 papers ident

d

Titles screened
545 abstracts reviewed
Abstracts screened
208 full texts reviewed for eligibility
Full text screened

School based delivery
n=12
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Community based
integrated delivery
n=7

Figure 1 Search flow diagram.

most common delivery strategy used in 12 [9,13-21,24,25]
studies targeting children aged five to 15 years, thirteen
[10,12,22,23,25-32,40] studies were non-integrated vertically delivered interventions, seven [11,33,34,36-39] were
integrated with primary healthcare (PHC), and routine
antenatal care (ANC) services. Almost all the studies had
a component on health education to promote general
hygiene and sanitation along with the drug administration.
Other co-interventions included iron and β-carotene supplementation, snail control, constructing latrines, eliminating cattle from the residential areas, staff training, and
community mobilization. One study [31] assessed the effectiveness of constructing a water recreation area in the
community using a local lake to prevent transmission of
schistosomiasis among school children. Most of the
studies provided combined drug treatment for the prevention and treatment of hookworms, ascariasis, trichuriasis, and schistosomiasis with the treatment regimen
including administration of albendazole (ALB) 400 mg
for STH and praziquantel (PZQ) 40 mg/kg for schistosomiasis, while mebendazole (MBZ) 500 mg was
used in four studies [11,14,27,37] and one study [14]
also administered pyrantel-oxantel (10 mg/kg). The
frequency of treatment varied according to the prevalence in the intervention area. We also attempted to conduct a subgroup analysis for the relative effectiveness of
preventive and therapeutic drug administration, integrated
and non-integrated delivery strategies, and evidence from
RCTs/quasi and pre-post studies separately, where possible, and reported the results accordingly. The results are
summarized in Tables 4 and 5.
Quantitative synthesis

Twelve studies reported STH prevalence, showing a significant 53% reduction in the overall STH prevalence

(RR: 0.47, 95% CI: 0.41, 0.54) rate, 60% reduction in
hookworm prevalence (RR: 0.40, 95% CI: 0.31, 0.52),
68% in ascariasis (RR: 0.32, 95% CI: 0.20, 0.51), and 34%
(RR: 0.66, 95% CI: 0.55, 0.80) in trichuriasis prevalence
(see Figure 2). Twenty-five studies pooled for schistosomiasis prevalence also showed a significant 59% overall reduction (RR: 0.41, 95% CI: 0.34, 0.50), with 59%
(RR: 0.41, 95% CI: 0.30, 0.57), 76% (RR: 0.24, 95% CI:
0.07, 0.80) and 52% (RR: 0.48, 95% CI: 0.36, 0.64) reductions in the prevalence of Schistosoma haematobium,
Schistosoma japonicum, and Schistosoma mansoni, respectively (see Figure 3). CBIs also significantly reduced
the mean STH intensity (SMD: −3.16, 95 CI: −4.28, −2.04).
Twelve studies reported on the hemoglobin (Hb) levels
and showed significantly improved mean Hb in the
intervention group (SMD: 0.34, 95% CI: 0.20, 0.47), while
anemia significantly reduced by 10% (RR: 0.90, 95% CI:
0.85, 0.96) (see Figures 4 and 5). Impacts on serum ferritin, weight, height and delivery outcomes of stillbirth,
low birth weight (LBW), and very LBW remained nonsignificant in the overall, as well as the subgroup, analyses.
Our subgroup analysis for the preventive and therapeutic drug administration showed that preventive drug
administration significantly reduced the overall prevalence
of STH (RR: 0.43, 95% CI: 0.31, 0.59), STH intensity
(SMD: −0.22, 95% CI: −0.26, −0.17), and schistosomiasis
prevalence (RR: 0.39, 95% CI: 0.27, 0.55), with nonsignificant impacts on ascariasis, trichuriasis, and Schistosoma haematobium prevalence. It also significantly
improved mean Hb (SMD: 0.19, 95% CI: 0.12, 0.26) and
reduced anemia prevalence (RR: 0.90, 95% CI: 0.85, 0.96)
and VLBW (RR: 0.38, 95% CI: 0.16, 0.87). Preventive
chemotherapy did not have a significant impact on serum
ferritin, height, weight, LBW, or stillbirths. Therapeutic
drug administration showed significant reductions in

Study

Study design Country

Intervention

Adam 1995 [13]

RCT

Kenya

Three doses of 400 mg ALB vs. identical placebo Children aged 5–10 years infected with
on three consecutive school days
hookworms or ascariasis

Target population

School-based

Integrated/Non-Integrated

Ageel 1997 [33]

Pre/post

Saudi Arabia

One oral dose of PZQ (40 mg/kg) + snail/vector
control + health education + community
participation

General population infected with
schistosomiasis

PHC

Albonico 2002 [14]

RCT

Tanzania

MBZ 500 mg vs. pyrantel-oxantel (10 mg/kg) vs.
placebo

Children aged 6–9 years

School-based

Bausch 1995 [35]

Quasi

Cameroon

Health education + PZQ

Children aged 5–15 years with
schistosomiasis

PHC + school-based

Beasely 1999 [25]

RCT

Tanzania

Single dose of 400 mg ALB + PPZQ (40 mg/kg)
vs. placebo

Infected children aged 7–12 years

Non-integrated

Bhargawa 2003 [15]

RCT

Tanzania

ALB 400 mg + PZQ single 40 mg/kg vs. placebo

Infected children aged 9–15 years

School-based

Christian 2009 [36]

RCT

Nepal

ALB 40 mg in 2nd + 3rd trimester

Pregnant women

Integrated with routine ANC

Dossa 2001 [26]

RCT

Benin

Iron (Fe) (60 mg/day) + ALB (200 mg for 3 days)
vs. FE + placebo vs. ALB + placebo vs. placebo
10 months F/V

Children aged 3–5 years

Non-integrated

Engels 1993 [11]

Pre/post

Burundi

Single dose PZQ (40 mg/kg), 50–150 mg
levamisole or 500 mg MBL or PZQ (20 mg/kg) +
snail vector control + education

General population

PHC

Gryseels 1991 [23]

Pre/post

Burundi

PZQ (40 mg/kg)

General population

Non-integrated

Gundersen 1990 [34]

Pre/post

Ethiopia

Vector snail control + 20 mg oxamniquine
followed by 40 mg the next day

General population

PHC

Guyatt 2001 [16]

Pre/post

Tanzania

Single dose 400 mg ALB + PZQ 40 mg/kg

School children aged 8–14 years

School-based

Halwindi 2011 [27]

RCT

Zambia

Facility vs. community detected and treatment + Children aged 12–months (preventive)
training + education + MBZ

Haque 2010 [28]

RCT

Bangladesh

400 mg ALB + B-carotene (2 doses) vs. ALB +
placebo vs. B-carotene + placebo vs. placebo +
placebo

Infected children aged 24–60 months

Non-integrated

Hathirat 1992 [24]

RCT

Thailand

Fe 50 mg FeSo 4 daily for 2 weeks then 100 mg
for 14wks vs. anthelminthic

Children aged 9–11 years

School-based

Kosinski 2012 [31]

Pre/post

Ghana

Water recreation area + PZQ

Children

Non-integrated
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Table 2 Characteristics of the included studies

Non-integrated

Pre/post

Uganda

PZQ

Children aged 7–14 years

School-based

Pre/post

Burkina Faso

PZQ 40 mg/kg + ALB 400 mg

Children aged 6–14 years

School-based

Larocque 2006 [37]

RCT

Peru

MBZ 500 mg single dose + 60 mg FE daily vs.
placebo + FE

Pregant women aged 18–44 years in the
2nd trimester

Integrated with routine ANC

Ndibazza 2010 [38]

RCT

Uganda

ALB (400 mg) vs. PZQ 40 mg/kg vs. ALB + PZQ
vs. placebo

Pregnant women

Integrated with routine ANC
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Koukounari 2006 [17]
Koukounari 2007 [18]

Nsowah-Nuamah 2001 [12]

Pre/post

Ghana

PZQ 40 mg/kg + passive edu vs. PZQ + no
education vs. PZQ + active edu vs. community
mobilization

Those aged 5 years and above

Non-integrated

Olds 1999 [29]

RCT

China and Philippines

ALB + PZQ vs. PZQ + ALB placebo vs. ALB + PZQ
placebo vs. placebo + placebo

Infected school aged children (4–18 years)

Non-integrated

Palupi 1997 [30]

RCT

Indonesia

FE + ALB 400 mg once a week vs. FE once a
week + placebo vs. placebo alone

Children aged 2–5 years

Non-integrated

Phuc 2009 [40]

Pre/post

Vietnam

IEC materials + staff training + Ferrous Sulphate/
folic acid (200 mg) + ALB (400 mg)

Women of reproductive age (16–45 years)

Non-integrated

Rohner 2010 [19]

RCT

Cote d’Ivoire

Iron fortified biscuits (20 mg fe/day) + IPT-SP
(500 mg sulphadoxine + 25 mg pyrimethamine) +
anthelminthic (400 mg-single) + PZQ (single –
40 mg/kg) in different combinations

School children aged 6–14 years

School-based

Savioli 1989 [9]

Pre/post

Tanzania

PZQ

Children

School-based

Sungthong 2002 [20]

RCT

Thailand

Deworming (400 mg ALB single) + daily or
weekly iron

Children aged 6–13 years

School-based

Sinoun 2007 [10]

Pre/post

Cambodia

Universal chemotherapy with PZQ (40 mg/kg)

General population

Non-integrated

Taylor 2001 [21]

RCT

South Africa

ALB (400 mg) + PZQ (40 mg/kg) + FE fumigate
200 mg weekly vs. ALB (400 mg) + PZQ (40 mg/
kg) + placebo weekly vs. ALB (400 mg) daily +
PZQ (40 mg/kg) + FE 200 mg weekly vs. ALB
(400 mg) + PZQ (40 mg/kg) + placebo weekly vs.
placebos + FE 200 mg weekly vs. placebos

Children aged 6–15 years

School-based

Torlesse 2001 [39]

RCT

Sierra Leone

FE + ALB vs. FE alone vs. ALB alone vs. placebo

Pregnant women (10–14 weeks)

Integrated with routine ANC

Wang 2009 [32]

Quasi

China

Health education + vector control + removing
cattle + latrines + PZQ

General population

Non-integrated

Zhang 2007 [22]

Pre/post

Uganda

PZQ (40 mg/kg) + ALB(400 mg) + education

School children and adults

Non-integrated
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Table 3 Quality assessment of the included RCTs
Study

Randomization

Sequence generation

Allocation
concealment

Blinding of
participants

Blinding of
assessors

Selective
reporting

Larocque 2006 [37]

Done

Done

Done

Done

Done

No

Ndibazza 2010 [38]

Done

Done

Done

Done

Done

No

Torlesse 2001 [39]

Done

Done

Not clear

Not clear

Not clear

Yes

Haque 2010 [28]

Done

Not clear

Not clear

Done

Not clear

No

Albonico 2002 [14]

Done

Done

Done

Done

Done

No

Taylor 2001 [21]

Done

Not clear

Not clear

Done

Done

Not clear

Adams 1994 [13]

Done

Not clear

Not clear

Done

Not clear

No

Beasley 1999 [25]

Done

Not computerized but done

Not clear

Not done

Done

No

Christian 2009 [36]

Not clear

Not clear

Not clear

Not Clear

Not Clear

Not clear

Halwindi 2011 [27]

Not clear

Not clear

Not applicable

Not applicable

Not clear

No

Olds 1999 [29]

Done

Not clear

Done

Done

Done

Not clear

Rohner 2010 [19]

Done

Not clear

Done

Done

Done

No

Bhargava 2003 [15]

Done

Not clear

Not clear

Not clear

Not clear

No

Palupi 1997 [30]

Done

Not clear

Not clear

Not clear

Not clear

No

Dossa 2001 [26]

Done

Not clear

Not clear

Done

Done

Yes

Hathirat 1992 [24]

Done

Not clear

Not clear

Done

Done

No

Sungthong 2002 [20]

Done

Done

Done

Done

Done

No

STH prevalence (RR: 0.52, 95% CI: 0.44, 0.61), intensity (SMD: −5.29, 95% CI: −9.22, −1.36), and schistosomiasis prevalence (RR: 0.41, 95% CI: 0.30, 0.55). Our analysis
did not show a significant impact of therapeutic chemotherapy on serum ferritin, Hb, weight, or height.
Findings from the subgroup analysis for school-based,
non-integrated, and integrated delivery strategies suggest
that school-based delivery significantly reduced STH
prevalence (RR: 0.49, 95% CI: 0.39, 0.63) and intensity
(SMD: −0.22, 95% CI: −0.26, −0.17), and the prevalence
of all types of schistosomiasis (RR: 0.50, 95% CI: 0.33,
0.75), with a non-significant impact on Schistosoma
mansoni. It also improved mean Hb (SMD: 0.24, 95% CI:
0.16, 0.32) and reduced anemia prevalence (RR: 0.87,
95% CI: 0.81-0.94) among school children. However,
school-based delivery did not show any significant impact on serum ferritin, height, and weight. Nonintegrated delivery reduced STH prevalence (RR: 0.52,
95% CI: 0.41, 0.67), intensity (SMD: −5.29, 95% CI: −
9.22, −1.36), and schistosomiasis prevalence (RR: 0.42,
95% CI: 0.31, 0.57), with a non-significant impact
on Schistosoma mansoni. Integrated delivery improved
schistosomiasis prevalence (RR: 0.24, 95% CI: 0.11, 0.5)
and overall STH prevalence (RR: 0.30, 95% CI: 0.12,
0.78), with non-significant impacts on the prevalence of
hookworm or trichuriasis.
Qualitative synthesis

Since most of the quantitative outcomes reported pertained to disease specific indicators, we also attempted

to qualitatively synthesize the findings reported in the
included studies on other pragmatic parameters from
our conceptual framework. CBIs have been reported
to achieve large-scale nationwide coverage as seen in
Burkina Faso, which was the first country in the WHO
African Region to achieve nationwide coverage with
anthelminthic drugs against three major NTDs: LF, schistosomiasis, and STH [18]. Furthermore, when delivered in
integration with the existing health systems, these programs can achieve maximum coverage as seen in the
Gizan region, where a vertically-oriented program, involving mobile teams for schistosome control, failed to achieve
the target of 80% population coverage and was costly to
sustain. The same program, when later on integrated with
the existing PHC, led to a significant increase in the numbers of patients examined and chemotherapy coverage.
Similarly in Zimbabwe and Burundi, schistosomiasis and
other control programs for NTDs have increasingly been
integrated into horizontal PHC systems [23]. The available
health infrastructure allows the control strategy to be very
well integrated into basic health services, enabling it to be
sustained and making it affordable for the national health
budget [11]. In a health system that generally enjoys a
strong structure from the provincial level down to the
community level, successful integration of these services
are relatively easier and just require making small modifications to the existing system. However, this process may
require more attention in countries where the health service structure is weak. The PHC approach has led to better coverage as compared to the vertical programs, and

Outcomes
STH Prevalence (RR)

Estimates (95% CI)
Combined

RCTs

Pre-post studies

Preventive

Therapeutic

0.47 [0.41, 0.54]

0.47 [0.41, 0.55]

0.51 [0.40, 0.65]

0.43 [0.31, 0.59]

0.52 [0.44, 0.61]

45 datasets from 12 studies

40 datasets from 9 studies

5 datasets from 3 studies

22 datasets from 7 studies

23 datasets from 5 studies

Hookworm

0.40 [0.31, 0.52]

0.41 [0.32, 0.54]

0.39 [0.23, 0.65]

0.26 [0.14, 0.45]

0.60 [0.46, 0.78]

15 datasets, 10 studies

13 datasets from 8 studies

2 datasets from 2 studies

8 datasets from 6 studies

7 datasets from 4 studies

Ascariasis

0.32 [0.20, 0.51]

0.30 [0.18, 0.49]

0.61 [0.41, 0.90]

0.62 [0.38, 1.01]

0.18 [0.08, 0.40]

15 datasets, 9 studies

14 datasets from 8 studies

1 dataset from 1 study

7 datasets from 4 studies

8 datasets from 5 studies

0.66 [0.55, 0.80]

0.65 [0.53, 0.79]

0.97 [0.68, 1.37]

0.57 [0.22, 1.46]

0.76 [0.66, 0.88]

14 datasets, 8 studies

13 datasets from 7 studies

1 dataset from 1 study

6 datasets from 3 studies

8 datasets from 5 studies

0.41 [0.34, 0.50]

0.42 [0.33, 0.54]

0.37 [0.25, 0.55]

0.39 [0.27, 0.55]

0.41 [0.30, 0.55]

Trichuriasis

Schistosomiasis Prevalence (RR)

Schistosoma Haematobium

25 datasets, 13 studies

16 datasets from 6 studies

9 datasets from 7 studies

11 datasets from 7studies

14 datasets from 6 studies

0.41 [0.30, 0.57]

0.43 [0.29, 0.64]

0.33 [0.17, 0.65]

0.59 [0.35, 1.02]

0.31 [0.18, 0.52]

10 datasets, 8 studies

6 datasets from 4 studies

4 datasets from 4 studies

3 datasets from 3 studies

7 datasets from 5 studies

Schistosoma Japonicum

0.24 [0.07, 0.80]

0.24 [0.07, 0.80]

No studies

0.11 [0.05, 0.26]

0.30 [0.07, 1.31]

4 datasets, 2 studies

4 datasets from 2 studies

1 dataset from 1 study

3 datasets from 1 study

Schistosoma Mansoni

0.48 [0.36, 0.64]

0.55 [0.38, 0.81]

0.39 [0.25, 0.62]

0.37 [0.24, 0.58]

0.67 [0.45, 1.01]

11 datasets, 7 studies

6 datasets from 2 studies

5 datasets from 5 studies

7 datasets from 5 studies

4 datasets from 2 studies

STH intensity (SMD)

−3.16 [−4.28, −2.04]

−5.29 [−9.22, −1.36]

−0.22 [−0.26, −0.17]

−0.22 [−0.26, −0.17]

−5.29 [−9.22, −1.36]

5 datasets, 3 studies

3 datasets from 1 study

2 datasets from 2 studies

2 datasets from 2 studies

3 datasets from 1 study

Hookworm

−2.22 [−3.27, −1.17]

−6.79 [−7.44, −6.14]

−0.22 [−0.26, −0.17]

−0.22 [−0.26, −0.17]

−6.79 [−7.44, −6.14]

Ascariasis

Trichuriasis

Mean hemoglobin (SMD)

Anemia

Height

1 dataset from 1 study

2 datasets from 2 studies

2 datasets from 2 studies

1 dataset from 1 study

−7.25 [−7.93, −6.56]

−7.25 [−7.93, −6.56]

No studies

No studies

−7.25 [−7.93, −6.56]

No Studies

No studies

−1.87 [−2.16, −1.57]

0.22 [0.13, 0.31]

0.19 [0.12, 0.26]

1.28 [−0.53, 3.08]

1 dataset, 1 study

1 dataset from 1 study

−1.87 [−2.16, −1.57]

−1.87 [−2.16, −1.57]

1 dataset, 01 study

1 dataset from 1 study

0.34 [0.20, 0.47]

0.43 [0.15, 0.71]

1 dataset from 1 study

1 dataset from 1 study

14 datasets, 12 studies

9 datasets from 7 studies

5 datasets from 5 studies

12 datasets from 10 studies

2 datasets from 2 studies

0.90 [0.85, 0.96]

0.92 [0.85, 1.00]

0.87 [0.78, 0.97]

0.90 [0.85, 0.96]

0.85 [0.69, 1.06]

9 datasets, 7 studies

5 datasets from 3 studies

4 datasets from 4 studies

8 datasets from 6 studies

1 dataset from 1 study

2.30 [−1.13, 5.73]

0.06 [−0.07, 0.18]

0.10 [−0.16, 0.37]

0.09 [−0.12, 0.29]

0.07 [−0.07, 0.20]

4 datasets, 4 studies

2 dataset from 2 studies

2 datasets from 2 studies

3 datasets from 3 studies

1 dataset from 1 study

0.01 [−0.10, 0.12]

−0.04 [−0.16, 0.08]

0.23 [−0.02, 0.49]

0.08 [−0.12, 0.28]

−0.02 [−0.15, 0.11]

4 datasets, 4 studies

3 datasets from 3 studies

1 dataset from 1 study

2 datasets from 2 studies

2 datasets from 2 studies
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Serum ferritin (SMD)

3 datasets, 03 studies
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Table 4 Results for the overall and subgroup analysis according to type of study and treatment

Weight

−0.13 [−0.42, 0.16]

−0.28 [−0.66, 0.11]

0.22 [−0.03, 0.47]

−0.01 [−0.48, 0.46]

−0.35 [−1.13, 0.42]

4 datasets, 4 studies

3 datasets from 3 studies

1 dataset from 1 study

2 datasets from 2 studies

2 data sets from 2 studies

−9.52 [−13.86, −5.19]

−9.52 [−13.86, −5.19]

No studies

−9.52 [−13.86, −5.19]

No study

6 datasets, 3 studies

6 datasets from 3 studies

0.96 [0.78, 1.18]

0.96 [0.78, 1.18]

4 datasets, 2 studies

4 datasets from 2 studies

0.48 [0.19, 1.19]

0.48 [0.19, 1.19]

4 datasets, 2 studies

4 datasets, 2 studies

1.54 [0.93, 2.58]

1.54 [0.93, 2.58]

3 datasets, 1 study

3 datasets from 1 study

Birth outcomes
Birth weight

LBW

VLBW

Stillbirths

*estimates in bold are statistically significant.

6 datasets from 3 studies
No studies

0.96 [0.78, 1.18]

No studies

4 datasets from 2 studies
No studies

0.48 [0.19, 1.19]

No studies

4 datasets, 2 studies
No studies

1.54 [0.93, 2.58]
3 datasets from 1 study

No studies
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Table 4 Results for the overall and subgroup analysis according to type of study and treatment (Continued)
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Outcomes
STH Prevalence (RR)

Hookworm

Ascariasis

Trichuriasis

Estimates (95% CI)
Combined

School-based delivery

Community-based non-integrated delivery

Community-based integrated delivery

0.45 [0.38, 0.54]

0.49 [0.39, 0.63]

0.52 [0.41, 0.67]

0.30 [0.12, 0.78]

45 datasets, 12 studies

19 datasets from 6 studies

16 datasets from 4 studies

9 datasets from 1 study

0.38 [0.27, 0.53]

0.37 [0.22, 0.62]

0.49 [0.29, 0.85]

0.25 [0.04, 1.62]

15 datasets, 10 studies

7 datasets from 5 studies

5 datasets from 3 studies

3 datasets from 1 study

0.32 [0.19, 0.52]

0.28 [0.09, 0.89]

0.36 [0.18, 0.74]

0.28 [0.09, 0.87]

15 datasets, 9 studies

4 datasets from 6 studies

6 datasets from 4 studies

3 datasets from 1 studies

0.66 [0.53, 0.82]

0.78 [0.67, 0.90]

0.76 [0.62, 0.94]

0.41 [0.07, 2.56]

14 datasets, 8 studies

4 datasets from 6 studies

5 datasets from 3 study

3 datasets from 1 studies

Schistosomiasis Prevalence (RR)

0.40 [0.33, 0.50]

0.50 [0.33, 0.75]

0.42 [0.31, 0.57]

0.24 [0.11, 0.56]

25 datasets, 13 studies

7 datasets from 5 studies

12 datasets from 4 studies

6 datasets from 4 studies

S. Haematobium

0.40 [0.29, 0.57]

0.59 [0.35, 1.02]

0.42 [0.26, 0.70]

0.05 [0.01, 0.45]

10 datasets, 8 studies

3 datasets from 3 studies

5 datasets from 3 studies

2 datasets from 2 studies

0.24 [0.06, 0.87]

No studies

0.24 [0.06, 0.87]

No studies

0.48 [0.35, 0.65]

0.44 [0.27, 0.74]

0.68 [0.42, 1.10]

S. Japonicum

4 datasets, 2 studies
S. Mansoni

4 datasets from 2 studies
0.38 [0.16, 0.91]

11 datasets, 7 studies

4 datasets from 4 studies

3 datasets from 1 study

4 datasets from 2 studies

STH intensity (SMD)

−3.16 [−4.28, −2.04]

−0.22 [−0.26, −0.17]

−5.29 [−9.22, −1.36]

No studies

5 datasets, 3 studies

2 datasets, 2 studies

3 datasets from 1 study

Hookworm

−2.22 [−3.27, −1.17]

−0.22 [−0.26, −0.17]

−6.79 [−7.44, −6.14]

Ascariasis

3 datasets, 3 studies

2 datasets, 2 studies

1 dataset from 1 study

−7.25 [−7.93, −6.56]

No studies

−7.25 [−7.93, −6.56]

No studies

−1.87 [−2.16, −1.57]

0.24 [0.16, 0.32]

0.93 [−0.33, 2.18]

1 dataset, 1 study
Trichuriasis

−1.87 [−2.16, −1.57]

No studies

No studies

1 dataset from 1 study

1 dataset, 1 study

No studies

1 dataset from 1 study

Mean hemoglobin (SMD)

0.34 [0.20, 0.47]
14 datasets, 12 studies

7 datasets from 7 studies

3 datasets from 3 studies

4 datasets from 2 studies

Anemia

0.90 [0.85, 0.96]

0.87 [0.81, 0.94]

0.85 [0.69, 1.06]

0.99 [0.90, 1.09]

Height

0.09 [−0.01, 0.20]

9 datasets, 7 studies

5 datasets from 5 studies

1 datasets from 1 study

3 datasets from 1 study

2.30 [−1.13, 5.73]

0.10 [−0.04, 0.25]

No studies

−0.01 [−0.36, 0.34]
No studies

4 datasets, 4 studies

3 datasets from 3 studies

0.01 [−0.10, 0.12]

0.04 [−0.08, 0.15]

−0.19 [−0.53, 0.14]

1 dataset from 1 study

4 datasets, 4 studies

3 datasets from 3 studies

1 dataset from 1 study
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Serum ferritin (SMD)
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Table 5 Summary estimates for the overall and subgroup analysis for school-based, non-integrated, and integrated delivery strategies

Weight

−0.13 [−0.42, 0.16]

−0.09 [−0.46, 0.27]

−0.27 [−0.60, 0.07]

4 datasets, 4 studies

3 datasets from 3 studies

1 dataset from 1 study

−9.52 [−13.86, −5.19]

No studies

No studies

No studies

Birth outcomes
Birth weight

6 datasets, 3 studies
LBW

0.96 [0.78, 1.18]

6 datasets from 3 studies
No studies

No studies

4 datasets, 2 studies
VLBW

0.38 [0.16, 0.87]

1.54 [0.93, 2.58]
3 datasets, 1 study

*Estimates in bold are statistically significant.

0.96 [0.78, 1.18]
4 datasets from 2 studies

No studies

No studies

4 datasets, 2 studies
Stillbirths

−9.52 [−13.86, −5.19]

0.38 [0.16, 0.87]
4 datasets from 2 studies

No studies

No studies

1.54 [0.93, 2.58]
3 datasets from 1 study
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Table 5 Summary estimates for the overall and subgroup analysis for school-based, non-integrated, and integrated delivery strategies (Continued)
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Figure 2 Forest plot for the impact of CBIs on STH prevalence.
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Figure 3 Forest plot for the impact of CBIs on schistosomiasis.

has been effective in reducing the overall prevalence of
helminthic infections.
CBIs have achieved a higher coverage without any increase in implementation costs at the district and health
facility levels. At the community level, there is an increase in ‘opportunity costs’ from community implementers who volunteer their time, thus forgoing other
remunerative activities. Some of the studies reported no

major direct additional costs incurred because the drugs,
training materials, and stationary were provided by the
PHC from their available resources, and the community
health workers (CHWs) were not given any monetary incentives. Hence, the major additional costs included the
indirect cost of labour hours for the CHWs and the
PHC staff during training and implementation of the
program. However, for national scale-up, the biggest

Salam et al. Infectious Diseases of Poverty 2014, 3:23
http://www.idpjournal.com/content/3/1/23

Page 13 of 17

Figure 4 Forest plot for the impact of CBIs on hemoglobin.

challenge is likely to be the cost of training and incentives for the CHWs [27]. Similarly, school-based delivery of preventive and promotive interventions is also
reported to be cost effective, however, its success depended on close supervision of the teachers’ compliance
with the program implementation, collaboration of the
educational authorities, and enthusiastic participation of

Figure 5 Forest plot for the impact of CBIs on anemia.

the school personnel [24]. On the contrary, in some endemic areas, an integrated delivery strategy has not been
successful in improving coverage because of the poor access to health services in remote areas. In view of the
strong commitment of national health authorities and
funding agencies to increase PHC coverage, rapid improvement of this situation can be expected. For sustained
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reduction in infection prevalence and complete eradication, periodic implementation is also necessary to ensure
continuity of morbidity control and achieve universal
coverage. In endemic areas, an intermittent intervention
delivery has shown to reduce the prevalence but did not
completely eradicate the infections. This might be attributable to the fact that chemotherapy reduces disease
prevalence only at the time of its administration and does
not prevent reinfection [32]. Hence, in endemic areas,
periodic implementation along with efforts to prevent reinfection is required.
Most of the studies support a multi-component strategy involving chemotherapy, health education, improved
water supply and sanitation, and snail control. Health
education and community involvement have been highlighted as essential components in any strategy for helminthic infection control and have been used in many
countries [12,22,33]. Examples of such successful programs are the chemotherapy program in Sudan where
village health committees served as facilitators, and in
Zimbabwe where CHWs were involved in the implementation of improvements to the water supply, sanitation, and in health education programs. Similarly in
Ethiopia and Egypt, local health personnel, farmers,
school health visitors, and teachers assisted in the implementation of successful control programs. Knowledge
and education plays an important role as, apparently,
the information motivates the participants and consequently ensures a higher level of compliance [30,40].
The process of designing the program, from its very initiation, should include open discussions and involvement
of all partners from the international to the local level.
This will ensure that everyone understands the goals,
benefits and underlying principles of the project, and
have the flexibility needed to adapt to particular local
conditions in order to achieve these goals [40]. Strong
commitment of all partners to the intervention has reportedly led to excellent participation levels and a significant clinical impact [34,40]. Besides health education
and community participation, the socioeconomic development leading to a general rise in living standards, improved sanitation and water supplies, construction of
drilled wells in rural areas, and a significant increase in
medical care also played a large part in the control of
helminthic NTDs [33]. Another important enabling factor was free distribution of drugs and supplies to ensure
equitable distribution to poor and marginalized groups,
which also helped avoid a complicated system of cost recovery and achieve high compliance levels.
Financial, logistical, and organizational limitations
were the major reported constraints in the long-term
sustainability of such programs. Despite considerable efforts and their high costs, the results of some of the vector control programs have been disappointing, largely
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because of poor weed control, lack of maintenance, and
the operational difficulty of covering entire networks,
which leads to rapid recolonization of treated sites.
Large-scale health education programs will not serve
their purpose if alternatives to traditional water contact
activities are not available. Maintenance is still reported
as a major hindrance and local authorities should try to
find adequate solutions. Annual tax payments, private latrine programs, subsidized prices, and credit facilities are
some of the counter strategies devised to overcome
these issues and ensure sustainability of such programs
after withdrawal of external funds [11]. Another major
challenge is to maintain a high level of participation and
enthusiasm as the project is integrated into the routine
provincial health program [40]. Although maximum
coverage has been achieved in the school-based programs, frequent migration of people (particularly from
the fishing communities), influx from neighboring countries, and absence from school of some school-aged children remain to be significant hurdles to the successful
implementation of the program [23]. Although often disregarded, religious, economic, and educational heterogeneity within communities may also impair disease
control efforts and, hence, these subtle demographic variables must be taken into account.

Discussion
The evidence in this review comes from efficacy and
effectiveness studies on CBIs for helminthic NTDs
compared to routine facility-based care or no intervention. Our review findings suggest that CBIs are effective
in reducing the prevalence of STH and schistosomiasis,
and STH intensity. They are also effective in improving
mean Hb and reducing anemia prevalence, but there
was non-significant impact on serum ferritin, height and
weight gain, LBW, and stillbirths. School-based delivery
was identified as a potential medium of delivery as it significantly reduced STH and schistosomiasis prevalence,
STH intensity, and anemia prevalence, however, there
was limited data available on the effectiveness of the
integrated and non-integrated delivery strategies. The
qualitative synthesis from the included studies supports
community-based delivery strategies and suggests that
integrated infection prevention and control measures are
more effective in achieving greater coverage compared
to the routine vertical delivery, albeit it requires an existing strong healthcare infrastructure. Systematic reviews
have been conducted on helminthic NTDs previously,
however, their scopes were either limited to a particular infection, drug efficacy or intervention, or the review did not evaluate the effectiveness of community
delivery strategies [41-45].
The WHO recommends periodic administration of anthelminthic medicines, mainly ALB and MBZ for STH,
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PZQ for schistosomiasis, and ivermectin or diethylcarbamazine citrate (DEC) for LF once or twice a year depending on the baseline prevalence of the infection to
control morbidity among the population at risk [46].
Health education is an essential component in the prevention and control of helminthiasis. Almost all the
studies in this review had a health education component
focusing on general hygiene and sanitation along with
the recommended drug administration. We did not find
any quantifiable data from studies on dracunculiasis, LF,
and onchocerciasis to be included in the pooled analysis.
Among these diseases, much progress has been made
for dracunculiasis and a significant reduction in dracunculiasis prevalence of more than 99% has been achieved
since 1989 [47]. Dracunculiasis is successfully at the
verge of eradication due to a combination of interventions including community-based surveillance systems,
intensified case-containment measures, and access to
safe drinking water. Globally, 1.39 billion people still require preventive chemotherapy for LF while 123 million
people are at risk of becoming infected with onchocerciasis [46,48]. Programs targeting LF and onchocerciasis
are in place in endemic countries, for example, the Global
Programme to Eliminate LF and the African Programme
for Onchocerciasis. These programs enable resourcelimited countries to make medicines freely available and
allow easy access to healthcare with a consequent reduction in infection prevalence [49].
Community delivery platforms are increasingly being
advocated for the prevention and control of major health
issues such as nutrition and childhood infection, and
hence could be feasible for helminthic NTDs [50,51].
Under these community platforms, integration of various disease specific programs is being encouraged for
onchocerciasis, LF, schistosomiasis, STH, and trachoma
[52,53]. The integrated delivery of interventions to control these diseases is more feasible and cost effective as
these diseases are endemic in specific geographical pockets where population are mostly co-infected and control mainly involves regular MDA of effective preventive
chemotherapy. Therefore, a package of drugs for more
than one NTD can be feasibly delivered. Critical factors
for successful integration include active support of relevant political and health authorities, a clear understanding by all parties of the health issues, and a simple
distribution process. However, there is limited data available to gauge the effectiveness of integrated delivery of
these programs along with other health programs
including routine ANC and PHC setups [54,55]. Schoolbased delivery has proven to be effective for the management and control of helminthic diseases as it requires a
minimum amount of training for school teachers to aid
implementation and hence doesn’t require an added workforce, whilst providing vast coverage at low costs [56].
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Conclusion
Current evidence emphasizes that effective communitybased strategies exist and deliver a range of preventive,
promotive, and therapeutic interventions to combat helminthic NTDs. However, there is a need to conduct
high-quality studies on the process of developing and
implementing an efficient integrated program as previous global programs have focused on the control of a
single NTD through a comprehensive approach. These
interventions exist within the current health systems in
most of the low- and middle-income countries, but there
is a need to implement them on a larger scale especially
to reach the unreachable.
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